Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$19.57 - $23.52 $15,929 - $19,145
-814 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$18.01 - $20.11 $6.23 Million - $6.96 Million
-346,164 Reduced 99.77%
814 $16,000
Q4 2018

Feb 12, 2019

SELL
$17.44 - $21.53 $3.37 Million - $4.16 Million
-193,387 Reduced 35.79%
346,978 $6.39 Million
Q3 2018

Nov 13, 2018

BUY
$19.97 - $21.96 $1.51 Million - $1.66 Million
75,418 Added 16.22%
540,365 $11.6 Million
Q2 2018

Aug 10, 2018

BUY
$20.16 - $24.68 $105,598 - $129,273
5,238 Added 1.14%
464,947 $9.99 Million
Q1 2018

May 10, 2018

BUY
$20.31 - $24.95 $403,051 - $495,132
19,845 Added 4.51%
459,709 $9.73 Million
Q4 2017

Feb 09, 2018

SELL
$20.99 - $23.89 $126,716 - $144,223
-6,037 Reduced 1.35%
439,864 $10 Million
Q3 2017

Nov 09, 2017

BUY
$20.07 - $21.89 $8.95 Million - $9.76 Million
445,901
445,901 $9.72 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.71B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.